In­fin­i­ty and MEI scrap merg­er af­ter un­so­licit­ed bid, lack of share­hold­er sup­port

In­fin­i­ty Phar­ma­ceu­ti­cals and MEI Phar­ma axed their all-stock merg­er af­ter the lat­ter re­ceived a lack of share­hold­er sup­port fol­low­ing an un­so­licit­ed pro­pos­al from ac­tivist in­vestors.

The com­pa­nies said Mon­day morn­ing that MEI’s share­hold­ers were near­ly split on the merg­er pro­pos­al, but those against the deal won out: About 2.05 mil­lion shares dis­ap­proved of the com­bi­na­tion, and 1.9 mil­lion shares were cast in sup­port, per an SEC fil­ing. Fol­low­ing Sun­day’s share­hold­er meet­ing, MEI told In­fin­i­ty it was ter­mi­nat­ing the deal since it need­ed stock­hold­er ap­proval.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER